Gabapentin Linked to Increased Dementia Risk ‌in Chronic Low Back Pain Patients

New research suggests a concerning association between gabapentin use and cognitive ⁣decline,particularly in younger adults.

Byline: Hannah ahmed – BMJ
Image Credit: Neuroscience News

A‍ recent study published in Regional anesthesia & Pain Medicine has shed light on a potential link⁣ between the prescription of gabapentin‌ for chronic low back pain and an increased risk of dementia ⁤and mild cognitive impairment. The findings,which⁢ analyzed​ a large national database,raise important questions for clinicians and patients alike regarding‍ the long-term ⁤cognitive effects of this commonly prescribed medication.

Understanding the Research

Gabapentin, a medication frequently enough used to manage neuropathic pain, seizures, and restless legs ‍syndrome, has become a staple in the ⁢treatment of chronic pain conditions, including chronic‍ low back pain. Though, its ⁣precise impact‌ on cognitive function over extended periods has remained⁤ a subject of ongoing investigation. This study aimed to clarify whether gabapentin⁤ prescription is associated with a higher incidence of ‍dementia in adults experiencing chronic low back pain.

Methodology: A deep Dive into Patient Data

The research team conducted a retrospective cohort‍ study,leveraging the ​extensive TriNetX ‍national ⁤database.​ This database comprises de-identified patient ⁢records spanning from 2004 ‍to 2024, offering a rich source ⁣of real-world clinical data.

The study included adults who had ⁣been diagnosed with chronic low back pain. Crucially, individuals with⁣ a​ history of gabapentin use prior to ⁤the study period, those‍ already diagnosed ‌with dementia, epilepsy, stroke, or cancer, were excluded to ensure the integrity of the findings.

To account for potential confounding factors,the researchers employed propensity score matching. This statistical technique helped to‌ balance the groups based on ⁣demographics, existing comorbidities, and the⁢ use of other pain medications. The patients were further stratified by⁤ age and the frequency of their gabapentin prescriptions. The primary outcomes of interest were the growth of dementia and mild cognitive impairment.

Key Findings: What the Data Revealed

The​ analysis encompassed 26,416 adults who were carefully matched using propensity scores. The results indicated a⁤ important association between gabapentin prescription and adverse​ cognitive outcomes.

Increased Risk with‌ Higher Prescription​ Frequency

Patients who received six or more gabapentin prescriptions demonstrated a notable increase in the incidence of dementia ​(Relative Risk [RR]: 1.29; 95% Confidence Interval​ [CI]: 1.18-1.40) and mild cognitive impairment (RR: 1.85; 95% CI: 1.63-2.10). This suggests that‌ the cumulative⁤ exposure to gabapentin may play a role in the observed cognitive changes.

Moreover, ⁣when examining prescription frequency, those⁤ with 12 or more prescriptions exhibited ⁤an even higher incidence‍ of dementia​ (RR: 1.40; 95% CI:‌ 1.25-1.57) and mild cognitive⁢ impairment ⁣(RR: 1.65; 95% CI: 1.42-1.91) compared to individuals who were prescribed gabapentin 3-11 times.This dose-dependent ⁣relationship underscores the importance of considering ​the duration and frequency of gabapentin ⁤therapy.

A Particularly​ vulnerable Group: ‍Non-Elderly⁢ Adults

Perhaps one of the most striking findings was the heightened risk observed in non-elderly adults ​(aged 18-64). This demographic, when⁢ prescribed gabapentin, showed over⁢ double the risk of developing dementia (RR: 2.10; 95% CI: 1.75-2.51) and mild ​cognitive impairment (RR: 2.50; 95% CI:⁣ 2.04-3.05) compared ‍to their counterparts⁤ who did not receive gabapentin. This⁣ finding challenges the common perception that cognitive decline is solely an issue for the elderly and highlights a potential vulnerability in younger populations.

Implications for Clinical ​Practice

The study’s conclusions carry significant weight for healthcare ‍providers managing patients with chronic low back ‌pain. The ⁢association between gabapentin prescription and increased⁣ risk of dementia and cognitive impairment, especially in younger ⁤adults, necessitates a cautious approach.

Physicians are encouraged to carefully monitor cognitive outcomes in patients who are ⁤prescribed gabapentin. This includes regular ‌assessments of memory,attention,and executive function,particularly for those on ​long-term or frequent treatment regimens. Exploring choice pain management strategies and considering the potential risks versus benefits